EDAP Announces University of Washington Medicine to Launch Focal One® Robotic HIFU Program
September 28, 2021 08:00 ET | EDAP TMS S.A.
Brings advanced focal ablation to prostate cancer patients in the Pacific Northwest LYON, France, September 28, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic...
FluroTest Provides System Development Update; Reports Saliva-based Point of Access Test System and Immunoassay for SARS-CoV-2 Detection is Fully Functional
September 16, 2021 08:00 ET | FluroTech Ltd.
CALGARY, Alberta, Sept. 16, 2021 (GLOBE NEWSWIRE) -- FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostic Systems ("FluroTest" or The Company), a diagnostics...
EDAP Announces Presentation of Multiple Abstracts Favorably Comparing HIFU to Surgery at the American Urological Association 2021 Annual Meeting
September 14, 2021 08:00 ET | EDAP TMS S.A.
Data demonstrate superiority of HIFU versus radical prostatectomy among prostate cancer patients LYON, France, September 14, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in...
EDAP to Participate at Upcoming Investor Conferences
September 07, 2021 16:35 ET | EDAP TMS S.A.
LYON, France, September 7, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), a global leader in robotic energy-based therapies, today announced that management will present at the following investor...
EDAP Reports Second Quarter 2021 Results and Provides Operational Update
August 25, 2021 16:35 ET | EDAP TMS S.A.
Total revenue for the first half 2021 of EUR 20.7 million (USD $24.8 million) increased 22.5% over the same period of the prior year Net income was EUR 0.4 million (USD 0.4 million), or EUR 0.01 per...
EDAP Announces Select Preliminary Unaudited Second Quarter 2021 Results
August 04, 2021 08:00 ET | EDAP TMS S.A.
Total company second quarter 2021 revenue of approximately EUR 10.4 million (USD $12.4 million) increased 11.8% year-over-year; first half 2021 total company revenue of EUR 20.7 million (USD $24.8...
EDAP Issues Letter to Shareholders
July 20, 2021 08:00 ET | EDAP TMS S.A.
Successful financing and hiring of MedTech industry veteran Ryan Rhodes to drive accelerated U.S. expansion efforts LYON, France, July 20, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the...
EDAP Announces Hiring of MedTech Industry Veteran Ryan Rhodes as CEO of Company’s U.S. Subsidiary
June 15, 2021 08:00 ET | EDAP TMS S.A.
Appointment brings highly experienced medical technology and commercialization leader to drive EDAP’s US expansion focus.Career accomplishments include 14 years at Intuitive Surgical, where he played...
EDAP Reports First Quarter 2021 Results and Provides Operational Update
May 11, 2021 16:30 ET | EDAP TMS S.A.
Generated record first quarter revenue of EUR 10.3 million (USD 12.4 million), an increase of 35.4% year-over-yearIncreased gross margin year-over-year to 42.4%, contributing to a profitable...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro Announces Partnership With D&K Engineering for Development of Robotic System for the MRI Suite and Operating Room
May 10, 2021 17:21 ET | ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...